Teamwork Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-12,188
Closed -$746K – 245
2021
Q4
$746K Sell
12,188
-3,973
-25% -$275K 0.14% 146
2021
Q3
$1.21M Sell
16,161
-1,391
-8% -$117K 0.24% 88
2021
Q2
$1.62M Sell
17,552
-2,175
-11% -$185K 0.33% 53
2021
Q1
$1.75M Sell
19,727
-1,510
-7% -$150K 0.41% 43
2020
Q4
$1.98M Buy
21,237
+2,794
+15% +$223K 0.47% 37
2020
Q3
$1.18M Buy
+18,443
New +$1.08M 0.36% 58

Other funds holding ARKG

Teamwork Financial Advisors's ARKG Position: Q1 2022 in Review

Teamwork Financial Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 12,188 shares — an estimated $746K sold.

Teamwork Financial Advisors first reported a position in ARKG in Q3 2020 and held it in 6 quarters. The position peaked at $1.98M in Q4 2020. 388 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

  • Teamwork Financial Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
  • Teamwork Financial Advisors sold 12,188 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $746K.
  • Teamwork Financial Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 6 quarters.
  • Teamwork Financial Advisors's ARK Genomic Revolution ETF position peaked at $1.98M in Q4 2020.
  • 388 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Teamwork Financial Advisors's 13F filing for Q1 2022, filed 18 Apr 2022.